Skip to content

Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting

Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07378839
Enrollment
100
Registered
2026-01-30
Start date
2026-02-10
Completion date
2027-03-31
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea, Pregnancy Emesis

Brief summary

This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.

Interventions

ANB 3 times per day for 5-10 minutes per session over a 7-day period

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pregnant individuals aged 18 years or older * Viable pregnancy with a gestational age between 6 0/7 - 12 6/7 weeks of gestation, confirmed by last menstrual period or ultrasound * Diagnosed with mild to moderate NVP (PUQE-24 score between 4-12) * Ability to understand and read English

Exclusion criteria

* Severe nausea and vomiting, defined as a PUQE score \>12, or diagnosis of hyperemesis gravidarum requiring hospitalization or intravenous fluid therapy * Pre-existing, active or acute respiratory conditions (e.g., asthma, COPD) * History of severe anxiety disorders affecting breathing patterns * Known deviated nasal septum * Nausea and vomiting that pre-dates the pregnancy or is suspected to be due to a etiology other than pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Severity of Nausea and VomitingDay 7Measured by the change in the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score, where scores range from 3-15, and a higher score indicates greater severity of nausea and vomiting.

Countries

United States

Contacts

CONTACTErin Wesley
obgynresearch@umn.edu612-624-9208
PRINCIPAL_INVESTIGATORShilpa Babbar

University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026